Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 30, Number 1—January 2024
Research Letter

Use of Doxycycline to Prevent Sexually Transmitted Infections According to Provider Characteristics

William S. PearsonComments to Author , Brian Emerson, Matthew Hogben, and Lindley Barbee
Author affiliation: Centers for Disease Control and Prevention, Atlanta, Georgia, USA

Main Article

Figure

Comparison of prophylactic use of doxycycline and beliefs about antimicrobial resistance among US STI providers and non-STI providers. *Indicates a statistical difference (p<0.05) according to χ2 analyses.

Figure. Comparison of prophylactic use of doxycycline and beliefs about antimicrobial resistance among US STI providers and non-STI providers. *Indicates a statistical difference (p<0.05) according to χ2 analyses.

Main Article

Page created: October 31, 2023
Page updated: December 20, 2023
Page reviewed: December 20, 2023
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external